Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $20.2900 (1.7%) ($19.5600 - $20.5700) on Tue. Sep. 10, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.48% (three month average) | RSI | 56 | Latest Price | $20.2900(1.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.1% a day on average for past five trading days. | Weekly Trend | IOVA advances 2.2% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -1.74% in a week (0% probabilities). VIXM(-28%) VXX(-15%) UUP(-10%) TLT(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.74% (StdDev 3.48%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
Resistance Level | $20.39 | 5 Day Moving Average | $20.72(-2.08%) | 10 Day Moving Average | $20.59(-1.46%) | 20 Day Moving Average | $20.39(-0.49%) | To recent high | -22% | To recent low | 7.2% | Market Cap | $2.971b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |